Opinion
2012-1228
03-28-2012
SCIELE PHARMA INC. (NOW KNOWN AS SHIONOGI PHARMA INC.), Plaintiff-Appellee, AND ANDRX CORPORATION, ANDRX PHARMACEUTICALS INC. (DOING BUSINESS AS WATSON LABORATORIES INC. - FLORIDA), ANDRX PHARMACEUTICALS L.L.C., ANDRX LABORATORIES (NJ) INC., ANDRX EU LTD., AND ANDRX LABS L.L.C., Plaintiffs, v. LUPIN LTD. AND LUPIN PHARMACEUTICALS INC., Defendants-Appellants, AND MYLAN INC. AND MYLAN PHARMACEUTICALS INC., Defendants.
NOTE: This order is nonprecedential.
Appeal from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0037, Judge Robert B. Kugler.
ON MOTION
ORDER
Upon consideration of the February 27, 2012 order expediting briefing on the merits of this appeal,
IT IS ORDERED THAT:
Oral argument for the merits of the appeal is scheduled to be held at 2 p.m., April 18, 2012 in Courtroom 402. The parties shall notify the clerk in writing of the name of the counsel who will present oral argument no later than April 6, 2012.
FOR THE COURT
Jan Horbaly
Clerk
cc: David B. Bassett, Esq.
Douglass C. Hochstetler, Esq.
s8